Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

SYF

Synchrony Financial Loan Book Hits $100.1 Billion

Synchrony Financial’s loan book edged up to $100.1 billion at March 31, 2026 from $99.9 billion a month earlier, while average loan receivables fell to $99.3 billion from $100.7 billion in February.

Delinquencies improved modestly. The 30+ delinquency rate declined to 4.5% in March from 4.7% in February, matching the 4.5% level seen in December and November and sitting below the 4.6% rate in January. A year earlier, the rate was also 4.5%.

Charge-offs were flat month over month. The net charge-off rate held at 5.8% in March, unchanged from February, but up from 4.7% in January. The adjusted net charge-off rate also stayed at 5.8% in March and February, compared with 4.7% in January.

Looking back over the prior year, the charge-off picture was more volatile. The net charge-off rate was 6.2% in March 2025, rose to 6.3% in April, then moved down to 5.1% in May and June before climbing back to 5.8% in July. It then ranged between 5.0% and 5.6% through January 2026 before returning to 5.8% in February and March.

Delinquency trends were steadier. The 30+ delinquency rate started at 4.5% in March 2025, dropped to 4.2% from May through July, then gradually rose to 4.7% in February 2026 before easing back to 4.5% in March.

Loan receivables were essentially unchanged over the year, moving from $99.6 billion in March 2025 to $100.1 billion in March 2026, with a high of $103.8 billion in December 2025. As a result of these announcements, the company's shares have moved -1.23% on the market, and are now trading at a price of $66.80. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS